Piperacillin And Tazobactam Injection, Powder, Lyophilized, For Solution
Product Images NDC 65219-436

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Piperacillin And Tazobactam (NDC 65219-436). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pip0b 0001 01

Pip0b 0001 01
Chemical structure of Piperacillin and Tazobactam showing the molecular arrangement with labeled functional groups and ring structures.*
FDA Label Image

Pip0b 0001 02

Pip0b 0001 02
Chemical structure diagram of the active ingredient Piperacillin and Tazobactam, showing the molecular components and bonds in a detailed 2D format.*
FDA Label Image

Pip0b 0001 03

Pip0b 0001 03
Packaging label for Piperacillin and Tazobactam injection, powder, lyophilized, for solution. The label shows container size, strength, and preparation information with Fresenius Kabi USA, LLC as the labeler. The label displays dosage forms for intravenous use and includes product code and manufacturing details.*
FDA Label Image

Pip0b 0001 04

Pip0b 0001 04
Label for Piperacillin and Tazobactam for Injection, USP, 2.25 grams per vial, lyophilized powder for intravenous use. The label states it is preservative-free and single-dose, with storage instructions before and after reconstitution. Labeler is Fresenius Kabi USA, LLC, with manufacturing in Italy. The label includes a barcode, lot, and expiration fields.*
FDA Label Image

Pip0b 0001 05

Pip0b 0001 05
Packaging label for Piperacillin and Tazobactam for Injection, USP, 2.25 grams per vial. The label indicates the product is a lyophilized powder for injection, intended for intravenous use only, preservative free. It is supplied by Fresenius Kabi USA, LLC in single-dose vials, with a package quantity of 10 vials.*
FDA Label Image

Pip0b 0001 06

Pip0b 0001 06
Label for Piperacillin and Tazobactam for Injection, USP, containing 3.375 grams per vial. The product is a single-dose vial for intravenous use only, preservative free, from Fresenius Kabi USA, LLC. Storage instructions and usage directions are included, highlighting the vial's contents and handling guidelines.*
FDA Label Image

Pip0b 0001 07

Pip0b 0001 07
Packaging label for Piperacillin and Tazobactam for Injection USP, 3.375 grams per vial, lyophilized powder for intravenous use. The label indicates preservative-free formulation and single-dose vials, with 10 vials per package. The labeler is Fresenius Kabi USA, LLC.*
FDA Label Image

Pip0b 0001 08

Pip0b 0001 08
Label for Piperacillin and Tazobactam for Injection, USP 4.5 grams per vial, a lyophilized powder for intravenous use. The label indicates it is for single-dose vials with no preservatives. It includes storage instructions before and after reconstitution, and specifies it is for Rx only. Manufactured by Fresenius Kabi USA, LLC.*
FDA Label Image

Pip0b 0001 09

Pip0b 0001 09
Packaging label for Piperacillin and Tazobactam for Injection, USP, 4.5 grams per vial. The product is a lyophilized powder for intravenous injection, preservative-free, and intended for single-dose vials. The label displays the strength, route, and labeler Fresenius Kabi USA, LLC, along with quantity information of 10 vials per package.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.